Nordic Capital Partners With Arcadia, Investing to Become Majority Owner

Arcadia Acquires CareJourney

June 27, 2024

Healthcare Services

Arcadia, a Boston-based healthcare data platform, acquired CareJourney, a provider of clinically relevant healthcare data and AI-powered analytics. The deal combines Arcadia’s platform and workflow tools with CareJourney’s claims-derived benchmarks and analytics to expand data breadth, accelerate analytics capabilities, and support value-based care for payers, providers, employers and government customers.

DMC Global Acquires 60% Controlling Interest in Arcadia Inc.

December 17, 2021

Building Products

DMC Global has signed a definitive agreement to acquire a 60% controlling interest in Arcadia Inc. for $282.5 million (cash and stock), with an option to acquire the remaining 40% over three years. The acquisition expands DMC's portfolio into architectural building products and will add Arcadia's ~850 employees and ~$246 million in trailing sales to DMC's operations.

Bansk Group Acquires Arcadia Consumer Healthcare from Avista Capital Partners

September 10, 2021

Consumer Products

Bansk Group, a New York-based private investment firm focused on consumer brands, agreed to acquire Arcadia Consumer Healthcare, a U.S. consumer health platform known for OTC medicines and premium vitamins and supplements, from Avista Capital Partners. The transaction (announced Aug. 9, 2021 and completed Sept. 10, 2021) positions Bansk to expand its consumer health and wellness portfolio and accelerate brand-building and M&A-driven growth.

Nordic Capital Acquires Majority Stake in IntegriChain from Accel-KKR

November 8, 2023

Cloud & SaaS

Nordic Capital has agreed to acquire a majority share in IntegriChain, a Philadelphia-based provider of a data-driven commercialization and market-access platform for the pharmaceutical industry, from Accel-KKR. The terms were not disclosed; closing is expected before year-end and is subject to customary regulatory and closing conditions.

Bansk Group Extends Investment in Arcadia Consumer Healthcare via Continuation Fund

January 20, 2026

Consumer Products

Bansk Group closed a continuation fund to extend its partnership with Arcadia Consumer Healthcare, with the transaction co-led by Coller Capital and Ares Secondaries Funds and supported by investment funds managed by BlackRock, Churchill, Dextra Partners, and Future Standard. The continuation structure provided liquidity to existing investors and supplies capital to accelerate Arcadia's organic and inorganic growth across its portfolio of OTC medicines, vitamins, and personal care brands.

Lee Equity Partners to Invest in Arcadian Risk Capital

October 6, 2025

Insurance

Arcadian Risk Capital entered into a strategic partnership with funds managed by Lee Equity Partners, a growth-oriented middle-market investment firm, to accelerate Arcadian’s expansion into new lines of business and geographies. The transaction is expected to close before the end of Q1 2026, subject to customary closing conditions and regulatory approvals, with SiriusPoint selling its entire 49% stake in Arcadian.